Abstract
Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. In recent years, pharmacovigilance has gained significant importance due to the increasing complexity of drugs, their wide use, and the risks associated with drug therapy. This article explores the role of pharmacovigilance in ensuring drug safety, particularly in the context of regulatory oversight, post-marketing surveillance, and the prevention of adverse drug reactions (ADRs). The article examines the significance of pharmacovigilance programs, the methods used for monitoring drug safety, and the importance of patient and healthcare provider reporting in detecting and mitigating risks. It also discusses challenges in the global pharmacovigilance system and highlights the future directions of pharmacovigilance, including the integration of big data and AI.